Osteoporosis is a major complication in patients with primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH). Denosumab, a fully human monoclonal antibody against the receptor activator of nuclear factor-κB ligand (RANKL), increases bone mineral density (BMD) by inhibiting development and ...
Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!